StemCell United Announces Plans for PO and Listing on ASX

摘要

Media Release StemCell United Announces Plans for PO and Listing on ASX Sydney, Australia. On Q Group Limited, changing its name to StemCell United Limited (SCU), a Singapore-based biotechnology company headquartered in Australia, has issued a prospectus for a Public Offering (PO) and listing on the Australian Securities Exchange (ASX) with the Australian Securities and Investment Commission (ASIC). The PO opens on 14 July 2015. The Company is announcing a public offer of 23,000,000 New Shares at the Offer Price of $0.20 per New Share (the "Offer").